100例小儿支气管肺炎住院患者用药方案分析

Analysis of Medication of 100 Hospitalized Patients with Bronchopneumonia in Children

目的:分析100例小儿支气管肺炎住院患者的用药情况。方法:回顾性分析本院儿科2017年1月—2018年12月确诊的100例支气管肺炎病例资料,根据治疗方案的不同将其分为五组,即A组(阿莫西林舒巴坦钠+喜炎平)、B组(阿莫西林舒巴坦钠+单磷酸阿糖腺苷)、C组(阿奇霉素+喜炎平)、D组(阿奇霉素+单磷酸阿糖腺苷)、E组(阿莫西林舒巴坦钠+阿奇霉素),每组20例。在痊愈出院的前提下,比较分析各组住院时间及在住院期间所产生的费用。结果:五组住院天数与住院费用相比较,差异具有统计学意义(P<0.05),其中C组住院天数最少、住院费用最低,B组住院天数最多、住院费用最高。结论:通过对比治疗小儿支气管肺炎5种方案的经济成本,旨在寻求一种高效且低廉的用药方案,为开展呼吸系统单病种循证药学工作提供依据和参考。

Objective:To analyze the medication of hospitalized patients with bronchopneumonia in children.Methods:The medical data of 100 pediatric cases of bronchopneumonia who diagnosed in the hospital from January 2017 to December 2018 were retrospectively analyzed.According to the different treatment plan,they were divided into 5 groups,namely A group(amoxicillin and sulbactam sodium+xiyanping),B Group(amoxicillin and sulbactam sodium+vidarabine monophosphate),C Group(azithromycin injection+xiyanping),D Group(azithromycin injection+vidarabine monophosphate),E Group(amoxicillin and sulbactam sodium+azithromycin injection),with 20 cases in each group.On the premise of recovery and discharge,the hospital stays and hospitalization expense were compared and analyzed.Results:There was statistical difference in the hospital stays and hospitalization expense among the five groups(P<0.05),the hospital stays and hospitalization expenses in C group were the lowest,and those in B group were the highest.Conclusion:By comparing the economic cost of the five schemes in the treatment of bronchopneumonia in children,an efficient and low-cost medication plan is found to provide basis and reference for the development of evidence-based pharmacological work on single respiratory disease.